Fairmount Funds Management LLC Terns Pharmaceuticals, Inc. Transaction History

Fairmount Funds Management LLC

  • $615 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$4.54 - $8.2 $5.86 Million - $10.6 Million
-1,291,004 Reduced 63.28%
748,996 $5.1 Million
Q4 2022

Feb 14, 2023
SELL
$4.62 - $10.18 $46,200 - $101,800
-10,000 Reduced 0.49%
2,040,000 $20.8 Million
Q3 2022

Nov 09, 2022
BUY
$1.87 - $6.42 $3.83 Million - $13.2 Million
2,050,000 New
2,050,000 $12.1 Million

Others Institutions Holding TERN

# of Institutions
167
Shares Held
78.3M
Call Options Held
580K
Put Options Held
454K
View Full List

About Terns Pharmaceuticals, Inc.

TERN Quotes by TradingView
  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Fairmount Funds Management LLC Portfolio

Follow Fairmount Funds Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairmount Funds Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email